Journal
Journal of the American Academy of Dermatology
Publication Date
7-1-2023
Volume
89
Issue
1
First Page
36
Last Page
44
Document Type
Open Access Publication
DOI
10.1016/j.jaad.2023.02.040
Rights and Permissions
Elewski BE, Lebwohl MG, Anadkat MJ, Barker J, Ghoreschi K, Imafuku S, Mrowietz U, Li L, Quaresma M, Thoma C, Bachelez H. Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study. J Am Acad Dermatol. 2023 Jul;89(1):36-44. doi: 10.1016/j.jaad.2023.02.040. Copyright 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Elewski, Boni E; Lebwohl, Mark G; Anadkat, Milan J; Barker, Jonathan; Ghoreschi, Kamran; Imafuku, Shinichi; Mrowietz, Ulrich; Li, Ling; Quaresma, Manuel; Thoma, Christian; and Bachelez, Hervé, "Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study." Journal of the American Academy of Dermatology. 89, 1. 36 - 44. (2023).
https://digitalcommons.wustl.edu/oa_4/2740
Department
ICTS (Institute of Clinical and Translational Sciences)
